Introduzca una acción o criptomoneda en el cuadro de búsqueda para obtener un resumen
Nipro Corp
5FANipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses. Its Medical-Related business develops, manufactures, and sells injection and infusion products, artificial organ products, functional products, dialysis products, diabetic products, and pharmaceuticals comprising generic and kit products; and manufactures medical equipment, including dialysis medical device products. This business also operates dialysis and training centers. The company's Pharmaceutical-Related business engages in the contract manufacturing of pharmaceutical products with containers for combination products, including injectable kit products consigned by other pharmaceutical companies. The business also provides injectable and oral drugs products. Its PharmaPackaging business offers pharmaceutical packaging containers and glass tubing, such as molded components for vials, syringes, rubber stoppers, and devices used to administer pharmaceuticals; and glass for thermos bottles, lighting and containers for combination products, as well glass for ampoules. It serves customers in Japan, the Americas, Europe, and rest of Asia. The company was founded in 1947 and is headquartered in Osaka, Japan. Address: 3-9-3, Osaka, Japan, 531-8510
Analytics
Precio Objetivo de WallStreet
224 946.75 JPYRelación P/E
26.8826Rentabilidad por dividendo
2.02 %Año en curso
Año anterior
Trimestre actual
Último trimestre
Año en curso
Año anterior
Trimestre actual
Último trimestre
Cifras clave 5FA
Análisis de dividendos 5FA
Aumento del dividendo durante 5 años
-38 %Crecimiento continuo
1 AñoRatio de pago medio en 5 años
28 %Tendencia del payout 5FA
Valoración de la acción 5FA
Finanzas 5FA
Realice un seguimiento de las métricas clave de cada acción en un solo lugar y sin complicaciones
Hazte premiumResultados | 2019 | Dinámica |